ReviewMedical2026

Unequal Burden: Sex Differences in Cannabis Withdrawal Symptom Severity in People With Multiple Sclerosis-A Short Report.

Meza C.; Feinstein A. · International journal of MS care · 2026

Research summary

**Background & Methods** This prospective study examined sex differences in cannabis withdrawal symptom severity among 19 frequent cannabis users with multiple sclerosis (11 women, 8 men) during 28 days of monitored abstinence. Withdrawal symptoms were assessed weekly using the Cannabis Withdrawal Questionnaire (CWQ), with abstinence verified by urinary THC-COOH metabolite ratios and mood evaluated using the Hospital Anxiety and Depression Scale (HADS) at baseline and day 28. **Key Findings** • Women reported significantly higher baseline CWQ scores than men and maintained elevated symptom burden through day 28, demonstrating a distinct time × sex interaction (Pillai trace = .784; P = .018; partial η² = .784) with different withdrawal trajectories between sexes. • Women experienced greater symptom severity across multiple withdrawal domains, including irritability, sleep disturbance, physical tension, nausea, and headaches compared to men. • Anxiety and depression scores remained stable and within normal limits for both sexes across the study period, suggesting that cannabis cessation is psychologically tolerable in people with MS despite physical withdrawal manifestations. **Dosage & Administration** Not reported. **Safety & Adverse Effects** Women with MS demonstrated a more pronounced withdrawal symptom burden than men, with specific adverse effects including irritability, sleep disturbance, physical tension, nausea, and headaches. The authors noted that these symptoms likely reflect both direct cannabis withdrawal effects and unmasking of underlying MS-related complaints during abstinence, complicating clinical differentiation. **Evidence Quality** This is a small pilot study (N=19) with significant limitations including modest sample size, unequal sex distribution (11 women vs. 8 men), lack of control group, and cross-sectional design limitations. The study provides preliminary evidence of sex-based differences in cannabis withdrawal but cannot establish causality. As a short report in a peer-reviewed journal, it represents lower-level evidence (observational/quasi-experimental design). Findings require validation in larger, controlled studies with balanced sex representation and longer follow-up periods. The authors appropriately acknowledge that symptom overlap between withdrawal and MS-related complaints limits interpretability, and generalizability to diverse MS populations remains unclear.

Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.

Journal
International journal of MS care
Year
2026
Study type
Review
Read the original paper (DOI) ↗
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed

More recent cannabis research

This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.

← Back to home